Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart M Sprague

Showing results (101-110 of 116) with videos related to

Pageof 12
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 21, 2005
Long-term treatment of secondary hyperparathyroidism with the calcimimetic cinacalcet HClSharon M Moe, John Cunningham, Jürgen Bommer, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 1, 2015
Diagnostic Accuracy of Bone Turnover Markers and Bone Histology in Patients With CKD Treated by DialysisStuart M Sprague, Ezequiel Bellorin-Font, Vanda Jorgetti, et al.
Journal of the American Society of Nephrology : JASN|May 14, 2015
Rationale and Approaches to Phosphate and Fibroblast Growth Factor 23 Reduction in CKDTamara Isakova, Joachim H Ix, Stuart M Sprague, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 26, 2004
Osteoporosis in chronic kidney diseaseJohn Cunningham, Stuart M Sprague, Jorge Cannata-Andia, et al.
Journal of the American Society of Nephrology : JASN|May 16, 2019
Effects of Nicotinamide and Lanthanum Carbonate on Serum Phosphate and Fibroblast Growth Factor-23 in CKD: The COMBINE TrialJoachim H Ix, Tamara Isakova, Brett Larive, et al.
Kidney International|August 5, 2019
Effect of bardoxolone methyl on the urine albumin-to-creatinine ratio in patients with type 2 diabetes and stage 4 chronic kidney diseasePeter Rossing, Geoffrey A Block, Melanie P Chin, et al.
Journal of Diabetes and Its Complications|October 16, 2018
Effects of bardoxolone methyl on body weight, waist circumference and glycemic control in obese patients with type 2 diabetes mellitus and stage 4 chronic kidney diseaseGlenn M Chertow, Gerald B Appel, Geoffrey A Block, et al.
Kidney360|February 7, 2024
Tenapanor as Therapy for Hyperphosphatemia in Maintenance Dialysis Patients: Results from the OPTIMIZE StudyStuart M Sprague, Daniel E Weiner, David P Tietjen, et al.
Kidney360|April 17, 2026
Correction to: Tenapanor as Therapy for Hyperphosphatemia in Maintenance Dialysis Patients: Results from the OPTIMIZE StudyStuart M Sprague, Daniel E Weiner, David P Tietjen, et al.
Kidney Medicine|July 26, 2023
Response to Alkali Administration in Women and Men With and Without CKDAlan C Pao, Sheikh R Shahzad, Shen Song, et al.
Pageof 12

Showing results (101-110 of 116) with videos related to

Sort By:
Pageof 12
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 21, 2005
Long-term treatment of secondary hyperparathyroidism with the calcimimetic cinacalcet HClSharon M Moe, John Cunningham, Jürgen Bommer, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 1, 2015
Diagnostic Accuracy of Bone Turnover Markers and Bone Histology in Patients With CKD Treated by DialysisStuart M Sprague, Ezequiel Bellorin-Font, Vanda Jorgetti, et al.
Journal of the American Society of Nephrology : JASN|May 14, 2015
Rationale and Approaches to Phosphate and Fibroblast Growth Factor 23 Reduction in CKDTamara Isakova, Joachim H Ix, Stuart M Sprague, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 26, 2004
Osteoporosis in chronic kidney diseaseJohn Cunningham, Stuart M Sprague, Jorge Cannata-Andia, et al.
Journal of the American Society of Nephrology : JASN|May 16, 2019
Effects of Nicotinamide and Lanthanum Carbonate on Serum Phosphate and Fibroblast Growth Factor-23 in CKD: The COMBINE TrialJoachim H Ix, Tamara Isakova, Brett Larive, et al.
Kidney International|August 5, 2019
Effect of bardoxolone methyl on the urine albumin-to-creatinine ratio in patients with type 2 diabetes and stage 4 chronic kidney diseasePeter Rossing, Geoffrey A Block, Melanie P Chin, et al.
Journal of Diabetes and Its Complications|October 16, 2018
Effects of bardoxolone methyl on body weight, waist circumference and glycemic control in obese patients with type 2 diabetes mellitus and stage 4 chronic kidney diseaseGlenn M Chertow, Gerald B Appel, Geoffrey A Block, et al.
Kidney360|February 7, 2024
Tenapanor as Therapy for Hyperphosphatemia in Maintenance Dialysis Patients: Results from the OPTIMIZE StudyStuart M Sprague, Daniel E Weiner, David P Tietjen, et al.
Kidney360|April 17, 2026
Correction to: Tenapanor as Therapy for Hyperphosphatemia in Maintenance Dialysis Patients: Results from the OPTIMIZE StudyStuart M Sprague, Daniel E Weiner, David P Tietjen, et al.
Kidney Medicine|July 26, 2023
Response to Alkali Administration in Women and Men With and Without CKDAlan C Pao, Sheikh R Shahzad, Shen Song, et al.
Pageof 12